I"&<table>
  <tbody>
    <tr>
      <td>Universal Standard</td>
      <td>IEEE Standard</td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Procedure (Static)</td>
      <td>3 pairs of measurements for each subject</td>
      <td>3 pairs of measurements for each subject OR the mean of all beats over a 20 s period for beat-to-beat devices</td>
      <td> </td>
    </tr>
    <tr>
      <td>Procedure (Test with BP change from calibration point)</td>
      <td>Not specified</td>
      <td>Dataset must include SBP changes of: -30 to -15 (13.6%), -15 to 0 (34.1%), 0-15 (34.1%), 15-30 (13.6%), and DBP changes of: -20 to -10 (13.6%), -10 to 0 (34.1%), 0-10 (34.1%), 10-20 (13.6%)</td>
      <td> </td>
    </tr>
    <tr>
      <td>Procedure (Test after certain period of time)</td>
      <td>Not specified</td>
      <td>Not specified</td>
      <td>Number of Subjects Required	85	20 (phase 1), 25 additional (phase 2)</td>
    </tr>
    <tr>
      <td>Demographics (healthy+diseased)</td>
      <td>adults study shall include ≥30% males and ≥30% females and shall have ≥5% of the reference systolic BP readings ≤100 mm Hg, ≥5% with ≥160 mmHg, and ≥20% with ≥140 mmHg and ≥5% of reference diastolic BP readings ≤60 mmHg, ≥5% with ≥100 mmHg, and ≥20% with ≥85 mmHg</td>
      <td>equal distribution (5, ≥6) of healthy, Prehypertension, Stage 1 Hypertension and Stage 2 Hypertension. Equal number of male and female subjects (≥22). All subjects between 18 and 65 years old.</td>
      <td> </td>
    </tr>
  </tbody>
</table>
:ET